Dr. Srivastava is a clinician-scientist who is strongly committed to cross-disciplinary patient-oriented research focused on the discovery and validation of novel non-invasive biomarkers that will identify high-risk patients with kidney diseases to optimize the conduct of clinical trials and serve as tools for drug development. Dr. Srivastava manages patients with acute and chronic kidney diseases with a distinct interest in optimizing medical therapy to reduce the risk of adverse clinical outcomes.